Trial reportPloS one2019
Double arterial cannulation strategy for acute type A aortic dissection repair: A 10-year single-institution experience.
Trial report in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.
- Double arterial vs. single axillary cannulation in acute type A aortic dissections: a meta-analysis.Future cardiology · 2024Pooled it
- Exploring the Effectiveness of Nursing Interventions for Postoperative Pain Management in Aortic Dissection: A Fuzzy Logic and Network Analysis.Journal of multidisciplinary healthcare · 2025Article
- A comparison of bilateral and unilateral cerebral perfusion for total arch replacement surgery for non-marfan, type A aortic dissection.Perfusion · 2024Article
- Acute type a aortic intramural hematoma complicated with preoperative hemopericardium: early and late surgical outcome analyses.Journal of cardiothoracic surgery · 2024Article
- Article
- Cannulation Strategies in Type A Aortic Dissection: Overlooked Details and Novel Approaches.Cureus · 2023Review
- Systematic Innominate Artery Cannulation Strategy in Acute Type A Aortic Dissection: Better Perfusion, Better Results.Journal of clinical medicine · 2023Article
- Left axillary cannulation for acute type A aortic dissection.Journal of cardiothoracic surgery · 2022Article
- Delayed sternal closure for intractable bleeding after acute type A aortic dissection repair: outcomes and risk factors analyses.Journal of cardiothoracic surgery · 2022Article
- Postoperative Stroke After Type A Aortic Dissection Repair: Hemorrhage Versus Ischemia.World journal of surgery · 2022Article
- Comparison of Single Axillary vs. Dual Arterial Cannulation for Acute Type a Aortic Dissection: A Propensity Score Matching Analysis.Frontiers in cardiovascular medicine · 2022Article
- Double arterial cannulation versus right axillary artery cannulation for acute type A aortic dissection: a retrospective study.Journal of cardiothoracic surgery · 2021Article
- Surgical outcomes of DeBakey type I and type II acute aortic dissection: a propensity score-matched analysis in 599 patients.Journal of cardiothoracic surgery · 2021Article
- Cannulation strategies in type A aortic dissection: a novel insight narrative review.Journal of thoracic disease · 2021Review
- En Bloc Arch Reconstruction With the Frozen Elephant Trunk Technique for Acute Type a Aortic Dissection.Frontiers in cardiovascular medicine · 2021Article
- Surgical results in acute type A aortic dissection with preoperative cardiopulmonary resuscitation: Survival and neurological outcome.PloS one · 2020Article
- Article
- Type A aortic dissection complicated by malperfusion syndrome.Current opinion in cardiology · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRepair of acute type A aortic dissection (ATAAD) is a complex and emergent cardiovascular surgery that is associated with high perioperative morbidity and mortality. Each cannulation strategy has different benefits and drawbacks during cardiopulmonary bypass. Using a retrospective study design, we aimed to clarify the safety and efficacy of right axillary artery cannulation in combination with femoral artery cannulation compared to single arterial cannulation for ATAAD repair.
methodsFrom January 2007 to July 2017, 476 adult patients underwent ATAAD repair at a single institution. Patients were classified into groups according to their cannulation strategy: the double arterial cannulation (DAC) group (n = 377; 79.2%) or single arterial cannulation (SAC) group (n = 99; 20.8%). Preoperative demographics, surgical information, and postoperative recovery were compared between both groups. Survival and freedom from reoperation rates were analyzed using the Kaplan-Meier actuarial method.
resultsDemographics, comorbidities, and surgical procedures were generally homogenous between the two groups, except for sex, age, and rate of extensive aortic repair. Patients who underwent DAC had lower in-hospital mortality (13.5% vs. 25.3%; P = 0.005) and lower incidence of malperfusion-related complications (18.8% vs. 30.3%; P = 0.011) than those who underwent SAC. During multivariate analysis, SAC was identified as an in-hospital mortality predictor (odds ratio, 2.81; 95% confidence interval, 1.52-5.17; P = 0.001), as were preoperative ventilator support, intraoperative extracorporeal membrane oxygenation installation, and postoperative malperfusion-related complications. Three-year cumulative survival and freedom from reoperation rates were 74.8% and 85.3% for the DAC group and 62.6% and 81.1% for the SAC group, respectively (P = 0.010 and 0.430, respectively).
conclusionsWith acceptable short- and mid-term outcomes, DAC is effective and safe for establishing cardiopulmonary bypass during ATAAD repair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.